Please login to the form below

Not currently logged in
Email:
Password:

New member for Baxterís board of directors

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007.

Hockmeyer founded MedImmune and served as its CEO and chairman from 1988 to 2000. MedImmune develops therapies for infectious disease, inflammatory disease and cancer and was recently acquired by AstraZeneca.

"Wayne is an exciting addition to our board of directors and we welcome the strong executive, scientific and operational experience he brings," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "His extensive scientific and R&D expertise will be invaluable in helping Baxter achieve its innovation and growth objectives."

Before Medimmune, Hockmeyer was vice-president of laboratory research and product development at Praxis Biologics and served as chief of the department of immunology at Walter Reed Army Institute of Research.

Hockmeyer is a member of the boards of directors of Middlebrook Pharmaceuticals, GenVec and Idenix Pharmaceuticals.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics